Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects
纳库巴坦 (OP0595) 静脉输注后的药代动力学、安全性和耐受性：一项在中国健康男性受试者中进行的随机、双盲、安慰剂对照的 I 期临床试验
期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-025-01951-1
Qiu, Hui; Wu, Tingting; Diao, Lei; Yu, Nianda; Chen, Hong; Peng, Xi; Jie Huang; Xie, Jinlian; Wu, Qian; Yang, Shuang; Yang, Xiaoyan; Zeng, Long; Pei, Qi; Guo, Chengxian; Yang, Guoping
